Safia K. Rizvi

Safia K. Rizvi currently serves as the Chief Executive Officer at CILA THERAPEUTICS, a position held since June 2018. Additionally, Rizvi is a Board Member at Kermode Biotechnologies and previously worked as the Chief Operating Officer at CARAVAN BIOLOGIX until February 2023. Prior roles include Managing Director at The Blue Group, Senior Vice President of Commercialization at Voyager Therapeutics, Inc., and various leadership positions at Nestlé Health Science, UCB, MedImmune, and GlaxoSmithKline Pharma GmbH. Rizvi's educational background includes an MBA in Health/Health Care Management from The Wharton School, a Board Room Ready certification from The George Washington University, and a Ph.D. in Chemistry/Biochemistry from the University of Oklahoma.